| Name | 2-[3-[[7-(3-chloropropoxy)quinazolin-4-yl]amino]-1H-pyrazol-5-yl]acetic acid |
|---|---|
| Synonyms |
S14-2740
2-(3-(7-(3-chloropropoxy)quinazolin-4-ylamino)-1h-pyrazol-5-yl)acetic acid (3-{[7-(3-chloropropoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)acetic acid (5-{[7-(3-chloropropoxy)quinazolin-4-yl]amino}-2H-pyrazol-3-yl)acetic acid |
| Molecular Formula | C16H16ClN5O3 |
|---|---|
| Molecular Weight | 361.78300 |
| Exact Mass | 361.09400 |
| PSA | 113.02000 |
| LogP | 2.80430 |
| HS Code | 2933990090 |
|---|
|
~79%
557770-91-9 |
| Literature: ASTRAZENECA AB; ASTRAZENECA UK LIMITED Patent: WO2004/58781 A1, 2004 ; Location in patent: Page 106-107 ; WO 2004/058781 A1 |
|
~%
557770-91-9 |
| Literature: Journal of Medicinal Chemistry, , vol. 50, # 9 p. 2213 - 2224 |
|
~%
557770-91-9 |
| Literature: Journal of Medicinal Chemistry, , vol. 50, # 9 p. 2213 - 2224 |
| Precursor 4 | |
|---|---|
| DownStream 2 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |